As AML is the second most common childhood leukemia, we utilized the TARGET pediatric study to analyze ETFA and ETFB expression and again found down-regulation or no significant change of ETFA and ETFB in most subtypes of AML (Supplementary Fig. 2A) [4]. This evidence concerns the gene ETFB and acute myeloid leukemia.